Innovations in Surgical Oncology at Roswell Park
In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques
Dissecting Cutaneous Oncology, One Layer at a Time
Wednesday, February 16th, 2022 | 5:00 - 6:30 PM EST
Benefits of Combining Beta-Blocker and Checkpoint Inhibitor
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Welcome to Roswell Park | Shalana O'Brien, MD
Shalana O'Brien, MD, is a highly skilled surgical oncologist treating patients with melanoma/skin cancers, endocrine disorders and cancers, and specializing in heated chemotherapy (HIPEC) to treat advanced cancers that have spread within the abdomen.
Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma
A central question in oncology is how to offer efficacious treatments while minimizing toxicity. This is especially true when treating advanced sarcoma and melanoma of the extremity.
Roswell Park Experts Use Gene Sequencing to Quantify Risk of Skin Cancer Long Before Damage is Visible
New findings could lead to better tools for the identification of at-risk individuals, earlier cancer prevention.
Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows
JAMA Oncology provides new insights that survival benefits are held regardless of BRAF mutation status or earlier targeted therapy.
This site is intended for healthcare professionals